News Solid Biosciences acquires AavantiBio, conducts $75 million ... The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a
News GSK abandons cough drug added in $2bn Bellus deal Three years after buying Bellus Health and its chronic cough candidate camlipixant for around $2 billion, GSK is abandoning the programme.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
